A. Eshleman

发表

Neurotransmitter action in osteoblasts: expression of a functional system for serotonin receptor activation and reuptake.

M. Bliziotes, A. Eshleman, X. Zhang, 2001, Bone.

Activation of Trace Amine-Associated Receptor 1 Stimulates an Antiapoptotic Signal Cascade via Extracellular Signal-Regulated Kinase 1/2

A. Janowsky, A. Eshleman, Xiao Shi, 2019, Molecular Pharmacology.

Mapping genes that regulate density of dopamine transporters and correlated behaviors in recombinant inbred mice.

J. Crabbe, A. Janowsky, R. A. Johnson, 2001, The Journal of pharmacology and experimental therapeutics.

The role of 5-HT2A, 5-HT2C and mGlu2 receptors in the behavioral effects of tryptamine hallucinogens N,N-dimethyltryptamine and N,N-diisopropyltryptamine in rats and mice

K. Rice, K. Cheng, M. Forster, 2014, Psychopharmacology.

Structure-Activity Relationships of Substituted Cathinones, with Transporter Binding, Uptake, and Release

A. Janowsky, A. Eshleman, T. Swanson, 2017, The Journal of Pharmacology and Experimental Therapeutics.

Serotonin transporter and receptor expression in osteocytic MLO-Y4 cells.

C. Chenu, B. Burt‐Pichat, M. Bliziotes, 2006, Bone.

Characterization of a recombinant human dopamine transporter in multiple cell lines.

K. Neve, R. Neve, A. Janowsky, 1995, The Journal of pharmacology and experimental therapeutics.

ATP enhances catecholamine uptake into PC12 cells.

A. Shamoo, M. Eldefrawi, A. Eshleman, 1995, Life sciences.

Melittin initiates dopamine transporter internalization and recycling in transfected HEK-293 cells.

A. Janowsky, A. Eshleman, K. Wolfrum, 2012, European journal of pharmacology.

Melittin stimulates fatty acid release through non-phospholipase-mediated mechanisms and interacts with the dopamine transporter and other membrane-spanning proteins.

A. Janowsky, A. Eshleman, D. Keith, 2011, European journal of pharmacology.

Abuse Liability Profile of Three Substituted Tryptamines

A. Janowsky, M. Forster, A. Eshleman, 2011, Journal of Pharmacology and Experimental Therapeutics.

A highly D3R-selective and efficacious partial agonist (S)-ABS01-113 compared to its D3R-selective antagonist enantiomer (R)-ABS01-113 as potential treatments for opioid use disorder

A. Janowsky, Z. Xi, A. Newman, 2022, Neuropsychopharmacology.

Lobeline effects on tonic and methamphetamine-induced dopamine release.

A. Janowsky, A. Eshleman, C. J. Wilhelm, 2008, Biochemical pharmacology.

Synthesis and Discovery of Arylpiperidinylquinazolines: New Inhibitors of the Vesicular Monoamine Transporter.

A. Janowsky, P. Meltzer, A. Eshleman, 2018, Journal of medicinal chemistry.

Effect of Iboga Alkaloids on µ-Opioid Receptor-Coupled G Protein Activation

A. Janowsky, K. Alper, S. Childers, 2013, PloS one.

Fentanyl but not Morphine Interacts with Nonopioid Recombinant Human Neurotransmitter Receptors and Transporters

A. Janowsky, A. Eshleman, T. Swanson, 2020, The Journal of Pharmacology and Experimental Therapeutics.

Pyrethroid insecticides indirectly inhibit GABA-dependent 36Cl− influx in synaptoneurosomes from the trout brain

T. F. Murray, A. Eshleman, 1991, Neuropharmacology.

A highly D3R-selective and efficacious partial agonist (S)-ABS01-113 compared to its D3R-selective antagonist enantiomer (R)-ABS01-113 as potential treatments for opioid use disorder

A. Janowsky, Z. Xi, A. Newman, 2022, Neuropsychopharmacology.

Neurochemical pharmacology of psychoactive substituted N‐benzylphenethylamines: High potency agonists at 5‐HT2A receptors

A. Janowsky, A. Eshleman, J. Reed, 2018, Biochemical pharmacology.

Substituted methcathinones differ in transporter and receptor interactions.

A. Janowsky, A. Eshleman, Robert A. Johnson, 2013, Biochemical pharmacology.

Uptake and Release of Neurotransmitters

K. Neve, A. Janowsky, A. Eshleman, 1998, Current protocols in neuroscience.

Verification of a genetic locus for methamphetamine intake and the impact of morphine

A. Janowsky, T. Phillips, A. Eshleman, 2017, Mammalian Genome.

Hydrogen ion concentration differentiates effects of methamphetamine and dopamine on transporter‐mediated efflux

A. Janowsky, A. Eshleman, C. J. Wilhelm, 2006, Journal of neurochemistry.

New dual 5-HT1A and 5-HT7 receptor ligands derived from SYA16263.

A. Janowsky, A. Eshleman, Chandrashekhar Voshavar, 2021, European journal of medicinal chemistry.

Neural regulation of bone and the skeletal effects of serotonin (5-hydroxytryptamine)

C. Turner, S. Warden, M. Bliziotes, 2005, Molecular and Cellular Endocrinology.

Allosteric regulation by sodium of the binding of [3H]cocaine and [3H]GBR 12935 to rat and bovine striata.

M. Eldefrawi, A. Eshleman, D. Calligaro, 1993, Membrane biochemistry.

Scaffold Repurposing of Nucleosides (Adenosine Receptor Agonists): Enhanced Activity at the Human Dopamine and Norepinephrine Sodium Symporters.

K. Jacobson, A. Janowsky, Zhang-Guo Gao, 2017, Journal of medicinal chemistry.

Genetic Polymorphisms Affect Mouse and Human Trace Amine-Associated Receptor 1 Function

Robert W. Williams, K. Neve, A. Janowsky, 2016, PloS one.

Cocaine increases human immunodeficiency virus type 1 neuroinvasion through remodeling brain microvascular endothelial cells

Marlys Witte, Jun Zhang, Francesco Chiappelli, 2005, Journal of NeuroVirology.

Synthesis of 3-carbamoylecgonine methyl ester analogues as inhibitors of cocaine binding and dopamine uptake.

R. H. Kline, M. Eldefrawi, A. Eshleman, 1991, Journal of medicinal chemistry.

[3H]substrate‐ and cell‐specific effects of uptake inhibitors on human dopamine and serotonin transporter‐mediated efflux

K. Neve, A. Janowsky, A. Eshleman, 1998, Synapse.

Release of dopamine via the human transporter.

K. Neve, A. Janowsky, R. Henningsen, 1994, Molecular pharmacology.

Characteristics of drug interactions with recombinant biogenic amine transporters expressed in the same cell type.

K. Neve, A. Janowsky, A. Eshleman, 1999, The Journal of pharmacology and experimental therapeutics.

Dependence on γ-aminobutyric acid of pyrethroid and 4′-chlorodiazepam modulation of the binding of t-[35S] butylbicyclophosphorothionate in piscine brain

T. F. Murray, A. Eshleman, 1990, Neuropharmacology.

Pyrethroid insecticide interaction with the GABAA receptor and the peripheral-type benzodiazepine receptor of rainbow trout brain

A. Eshleman, 1990 .

Differential Binding Properties of the Peripheral‐Type Benzodiazepine Ligands [3H]PK 11195 and [3H]Ro 5‐4864 in Trout and Mouse Brain Membranes

T. F. Murray, A. Eshleman, 1989, Journal of neurochemistry.

Mefloquine and psychotomimetics share neurotransmitter receptor and transporter interactions in vitro

A. Janowsky, Jong-Moon Yang, D. Hinrichs, 2014, Psychopharmacology.

Development of a Translational Model to Assess the Impact of Opioid Overdose and Naloxone Dosing on Respiratory Depression and Cardiac Arrest

D. Strauss, Zhihua Li, A. Janowsky, 2022, Clinical pharmacology and therapeutics.

Structure-activity relationships of bath salt components: substituted cathinones and benzofurans at biogenic amine transporters

A. Janowsky, A. Eshleman, Aaron Nilsen, 2018, Psychopharmacology.

Mefloquine and psychotomimetics share neurotransmitter receptor and transporter interactions in vitro

A. Janowsky, Jong-Moon Yang, D. Hinrichs, 2014, Psychopharmacology.

The role of 5-HT2A, 5-HT2C and mGlu2 receptors in the behavioral effects of tryptamine hallucinogens N,N-dimethyltryptamine and N,N-diisopropyltryptamine in rats and mice

K. Rice, M. Forster, A. Eshleman, 2014, Psychopharmacology.

Affinity, potency, efficacy, selectivity, and molecular modeling of substituted fentanyls at opioid receptors.

A. Janowsky, A. Eshleman, Aaron Nilsen, 2020, Biochemical pharmacology.

Ovarian steroid regulation of serotonin reuptake transporter (SERT) binding, distribution, and function in female macaques*

A. Janowsky, C. Bethea, N. Lu, 2003, Molecular Psychiatry.

Behavioral and neurochemical pharmacology of six psychoactive substituted phenethylamines: mouse locomotion, rat drug discrimination and in vitro receptor and transporter binding and function

A. Janowsky, M. Forster, A. Eshleman, 2014, Psychopharmacology.

GABAB receptor activation attenuates the stimulant but not mesolimbic dopamine response to ethanol in FAST mice

S. E. Holstein, T. Phillips, A. Eshleman, 2013, Behavioural Brain Research.

Repurposing of a Nucleoside Scaffold from Adenosine Receptor Agonists to Opioid Receptor Antagonists

K. Jacobson, A. Janowsky, Zhang-Guo Gao, 2018, ACS omega.

Pharmacologic Activity of Substituted Tryptamines at 5-Hydroxytryptamine (5-HT)2A Receptor (5-HT2AR), 5-HT2CR, 5-HT1AR, and Serotonin Transporter

A. Abbas, A. Janowsky, A. Eshleman, 2023, The Journal of Pharmacology and Experimental Therapeutics.

Behavioral and neurochemical pharmacology of six psychoactive substituted phenethylamines: mouse locomotion, rat drug discrimination and in vitro receptor and transporter binding and function

A. Janowsky, M. Forster, A. Eshleman, 2013, Psychopharmacology.

NMDA receptor subunit mRNA and protein expression in ethanol-withdrawal seizure-prone and -resistant mice.

J. Crabbe, A. Janowsky, J. Belknap, 2001, Alcoholism, clinical and experimental research.

Drug interactions with the dopamine transporter in cryopreserved human caudate.

D. Mash, A. Janowsky, A. Eshleman, 2001, The Journal of pharmacology and experimental therapeutics.

Effects of Methamphetamine and Lobeline on Vesicular Monoamine and Dopamine Transporter-Mediated Dopamine Release in a Cotransfected Model System

A. Janowsky, P. Lysko, A. Eshleman, 2004, Journal of Pharmacology and Experimental Therapeutics.

Rigid Adenine Nucleoside Derivatives as Novel Modulators of the Human Sodium Symporters for Dopamine and Norepinephrine

K. Jacobson, A. Janowsky, D. Tosh, 2016, The Journal of Pharmacology and Experimental Therapeutics.

The role of dopamine and serotonin in regulating bone mass and strength: studies on dopamine and serotonin transporter null mice.

M. Bliziotes, A. Eshleman, K. Wiren, 2002, Journal of musculoskeletal & neuronal interactions.

Structure-activity relationships of bath salt components: substituted cathinones and benzofurans at biogenic amine transporters

A. Janowsky, A. Eshleman, Aaron Nilsen, 2018, Psychopharmacology.

Structure-Activity Relationships of Substituted Cathinones, with Transporter Binding, Uptake, and Release

A. Janowsky, A. Eshleman, J. Reed, 2017, The Journal of Pharmacology and Experimental Therapeutics.